Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
FS120 for Advanced Cancer
Recruiting1 awardPhase 1
Salt Lake City, Utah
This trial is testing FS120, a medicine that strengthens the immune system, alone and with Pembrolizumab, which helps the immune system attack cancer, in patients with advanced cancer. Pembrolizumab is a medicine used to treat various cancers by enhancing the immune system's ability to attack cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service